The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Eisai
Speakers' Bureau - Eisai
Research Funding - Eisai (Inst)
A phase Ib/II study of eribulin (ERI) plus pembrolizumab (PEMBRO) in metastatic triple-negative breast cancer (mTNBC) (ENHANCE 1).
 
Sara M. Tolaney
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celldex; Eisai; G1 Therapeutics; Genentech; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Odonate Therapeutics; Paxman; Pfizer; Puma Biotechnology; Sanofi; Seagen; Silverback Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celldex; Eisai; Genentech/Roche; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
 
Kevin Kalinsky
Stock and Other Ownership Interests - Array BioPharma (I); Novartis (I); Pfizer (I)
Consulting or Advisory Role - Amgen; AstraZeneca; bioTheranostics; Eisai; Genentech/Roche; immunomedics; Ipsen; Lilly; Novartis; Odonate Therapeutics; pfizer
Speakers' Bureau - Lilly
Research Funding - Acetylon Pharmaceuticals (Inst); Amgen (Inst); Calithera Biosciences (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Zeno Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Genentech; Lilly; Novartis; Pfizer
Other Relationship - Genentech; Immunomedics
 
Virginia G. Kaklamani
No Relationships to Disclose
 
David R. D'Adamo
Employment - Eisai
 
Gursel Aktan
Employment - Merck; Merck (I)
Stock and Other Ownership Interests - Merck; Merck (I)
Travel, Accommodations, Expenses - Merck; Merck (I)
 
Michaela L. Tsai
No Relationships to Disclose
 
Ruth O'Regan
Honoraria - bioTheranostics; Genentech; Genomic Health; Immunomedics; Lilly; Macrogenics; Novartis; Pfizer; Puma Biotechnology
Consulting or Advisory Role - bioTheranostics; Genentech; Genomic Health; ImmunogenX; Lilly; Macrogenics; Novartis; Puma Biotechnology
Research Funding - Cascadian Therapeutics (Inst); Eisai (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Genomic Health; Immunomedics; Lilly; Macrogenics; Puma Biotechnology
 
Peter A. Kaufman
Stock and Other Ownership Interests - Amgen
Honoraria - Lilly
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Macrogenics; Merck; Pfizer; Polyphor; Roche/Genentech
Speakers' Bureau - Lilly; Teva
Research Funding - Eisai (Inst); Lilly (Inst); Macrogenics (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Lilly; Macrogenics; Polyphor
 
Sharon Wilks
Research Funding - Seagen (Inst)
 
Eleni Andreopoulou
Honoraria - Abbvie; AstraZeneca; Eisai; NanoString Technologies; Sirtex Medical; SVB Leerink
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; NanoString Technologies; Sirtex Medical; SVB Leerink
Speakers' Bureau - R-Pharm
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Eisai; NanoString Technologies; Sirtex Medical; SVB Leerink
 
Debra A. Patt
Employment - McKesson; MedNax (I); Texas Oncology
Leadership - McKesson; Mednax (I); Texas Oncology
Stock and Other Ownership Interests - Mednax (I)
Speakers' Bureau - Pfizer
Research Funding - Eisai (Inst); Lilly (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - McKesson
 
Yuan Yuan
Consulting or Advisory Role - Eisai; Genentech; Immunomedics; Novartis; Pfizer
Speakers' Bureau - Eisai; Genentech
Research Funding - Eisai; Genentech; Merck; Novartis; Pfizer; Puma Biotechnology
Expert Testimony - Novartis
 
Grace Wang
Research Funding - Eisai (Inst)
 
Dongyuan Xing
Employment - Eisai
 
Ella Kleynerman
Employment - Eisai
 
Vassiliki Karantza
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Sami Diab
Stock and Other Ownership Interests - Bluebird Bio; Conatus; Immunogen; Immunomedics; Novocure; Viking Medical
Honoraria - Agendia; AstraZeneca; Genomic Health; Lilly; Myriad Genetics; Novartis; Pfizer
Consulting or Advisory Role - Agendia; Genentech; Genomic Health; Lilly; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology
Speakers' Bureau - Agendia; Genentech; Genomic Health; Lilly; Novartis; Pfizer; Puma Biotechnology
Research Funding - Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech; Lilly; Novartis; Pfizer